MAHONEY DAVID L 4
4 · CORCEPT THERAPEUTICS INC · Filed May 9, 2023
Insider Transaction Report
Form 4
MAHONEY DAVID L
Director
Transactions
- Exercise/Conversion
Common Stock
2023-05-08$1.74/sh+30,000$52,200→ 1,239,275 total(indirect: By Trust) - Tax Payment
Common Stock
2023-05-08$23.76/sh−2,197$52,201→ 1,237,078 total(indirect: By Trust) - Exercise/Conversion
Stock option (right to buy)
2023-05-08−30,000→ 0 totalExercise: $1.74Exp: 2023-05-17→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on May 8, 2023. The options subject to the net exercise were to expire on May 17, 2023.
- [F2]Fully exercisable.